Terrie Kellmeyer
Fortune : - $ au 31/05/2026
Fortune : - $ au 31/05/2026
Terrie Kellmeyer is currently Chief Executive Officer at Anavex Life Sciences Corp., a position starting in 2026.
Former roles include Senior Vice President-Regulatory Affairs at Aardvark Therapeutics, Inc. from 2025 to 2026, Group Vice President-Clinical Development at Acer Therapeutics, Inc., and Head-Global Regulatory Affairs at Madrigal Pharmaceuticals, Inc. Education includes an undergraduate degree from Rochester Institute of Technology and a doctorate from The State University of New York.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ANAVEX LIFE SCIENCES CORP. | Directeur Général | 04/05/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| AARDVARK THERAPEUTICS, INC. | Conseiller Juridique Général | 01/05/2026 |
| ACER THERAPEUTICS INC. | Directeur Technique/Scientifique/R&D | - |
| MADRIGAL PHARMACEUTICALS, INC. | Conseiller Juridique Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Rochester Institute of Technology
Rochester Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The State University of New York
The State University of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anavex Life Sciences Corp.
Anavex Life Sciences Corp. BiotechnologyHealth Technology Engages in the development of innovative drug compounds | Health Technology |
Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs for cardiovascular, metabolic and liver diseases | Health Technology |
Acer Therapeutics, Inc.
Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for serious rare and life-threatening diseases | Health Technology |
Aardvark Therapeutics, Inc.
Aardvark Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapeutics for obesity and metabolic diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national